Inositol Phosphoglycan P-Type in Preeclampsia
Authors:
- 1 January 2007
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (1) , 84-89
Abstract
A state of insulin resistance has been demonstrated in active preeclampsia, and women with clinical evidence of insulin resistance are at higher risk to develop this syndrome during pregnancy. Recently, inositol phosphoglycan P-type, a putative second messenger of insulin action, has been implicated in the pathophysiology of preeclampsia and is increased in the placenta, amniotic fluid, and maternal urine of preeclamptic women compared with normal pregnant women. We report here a case–control study to assess the potential of urinary levels of inositol phosphoglycan P-type as a screening test for preeclampsia. Twenty-seven preeclamptic women and 47 healthy pregnant women were recruited. A polyclonal antibody-based ELISA was developed to detect levels of inositol phosphoglycan P-type in urine. Its content in urinary specimens was found to be 30-fold higher in preeclamptic subjects than control subjects (329.1±21.8 versus 9.2±1.5; P 1 gestational date sample of urine was available, and retrospective analysis showed a significant time-related increase of the urinary level of inositol phosphoglycan P-type ≤7 weeks before clinical diagnosis of preeclampsia. Urinary level of inositol phosphoglycan P-type increased after diagnosis indicating a possible pathophysiological threshold level and steeply decreased after delivery.Keywords
This publication has 28 references indexed in Scilit:
- P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsiaJournal of Reproductive Immunology, 2006
- Insulin Resistance in Human Preeclamptic Placenta Is Mediated by Serine Phosphorylation of Insulin Receptor Substrate-1 and -2The Journal of Clinical Endocrinology & Metabolism, 2006
- Pre-eclampsiaThe Lancet, 2005
- Inositol Phosphoglycans and Signal Transduction Systems in Pregnancy in Preeclampsia and Diabetes: Evidence for a Significant Regulatory Role in Preeclampsia at Placental and Systemic LevelsMolecular Genetics and Metabolism, 2000
- Evidence of a state of increased insulin resistance in preeclampsiaMetabolism, 1999
- Structure−Activity Relationship of Synthetic Phosphoinositolglycans Mimicking Metabolic Insulin ActionBiochemistry, 1998
- Cell signalling by inositol phosphoglycans from different speciesComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1996
- Hyperinsulinemia in glucose-tolerant women with preeclampsia A controlled studyAmerican Journal of Hypertension, 1996
- Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles.Journal of Clinical Investigation, 1993
- Obstetric Complications With GDM: Effects of Maternal WeightDiabetes, 1991